(ZBRA) Zebra Technologies - Overview
Stock: Barcode Printers, RFID Readers, Mobile Computers, Scanners, Software
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 37.1% |
| Relative Tail Risk | -6.72% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.73 |
| Alpha | -58.89 |
| Character TTM | |
|---|---|
| Beta | 1.696 |
| Beta Downside | 1.925 |
| Drawdowns 3y | |
|---|---|
| Max DD | 49.29% |
| CAGR/Max DD | -0.15 |
Description: ZBRA Zebra Technologies January 03, 2026
Zebra Technologies (NASDAQ: ZBRA) delivers enterprise-asset-intelligence solutions across two segments-Asset Intelligence & Tracking and Enterprise Visibility & Mobility-by designing, manufacturing, and servicing a broad portfolio that includes label and card printers, RFID-enabled devices, rugged mobile computers, barcode scanners, and cloud-based software subscriptions.
In FY 2023 the company generated roughly **$9.2 billion** in revenue, with the **RFID and real-time location systems (RTLS) businesses driving a 14 % YoY increase**, reflecting heightened demand for automated inventory and asset visibility in logistics and healthcare. The segment’s operating margin hovered around **13 %**, underscoring strong pricing power amid a competitive landscape.
Key macro drivers for Zebra include the **global e-commerce surge (projected to grow >10 % CAGR through 2027)**, which fuels label-printing and barcode-scanning volumes, and **persistent labor shortages** that accelerate adoption of RFID-based automation and prescriptive analytics to reduce manual handling costs. Additionally, the broader **IoT and Industry 4.0 trends** support the company’s push into sensor-enabled tags and cloud-managed services.
For a deeper, data-driven valuation framework, you may find ValueRay’s analytical tools worth exploring.
Piotroski VR‑10 (Strict, 0-10) 7.0
| Net Income: 512.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.10 > 0.02 and ΔFCF/TA -0.17 > 1.0 |
| NWC/Revenue: 18.52% < 20% (prev 12.26%; Δ 6.25% < -1%) |
| CFO/TA 0.11 > 3% & CFO 866.0m > Net Income 512.0m |
| Net Debt (1.31b) to EBITDA (1.06b): 1.23 < 3 |
| Current Ratio: 1.61 > 1.5 & < 3 |
| Outstanding Shares: last quarter (51.8m) vs 12m ago -0.21% < -2% |
| Gross Margin: 48.39% > 18% (prev 0.48%; Δ 4792 % > 0.5%) |
| Asset Turnover: 66.70% > 50% (prev 60.55%; Δ 6.15% > 0%) |
| Interest Coverage Ratio: 4.62 > 6 (EBITDA TTM 1.06b / Interest Expense TTM 194.0m) |
Altman Z'' 4.91
| A: 0.12 (Total Current Assets 2.58b - Total Current Liabilities 1.60b) / Total Assets 8.07b |
| B: 0.65 (Retained Earnings 5.21b / Total Assets 8.07b) |
| C: 0.11 (EBIT TTM 896.0m / Avg Total Assets 7.88b) |
| D: 1.19 (Book Value of Equity 5.15b / Total Liabilities 4.32b) |
| Altman-Z'' Score: 4.91 = AAA |
Beneish M -3.07
| DSRI: 0.95 (Receivables 761.0m/709.0m, Revenue 5.25b/4.66b) |
| GMI: 0.98 (GM 48.39% / 47.53%) |
| AQI: 0.94 (AQ_t 0.62 / AQ_t-1 0.66) |
| SGI: 1.13 (Revenue 5.25b / 4.66b) |
| TATA: -0.04 (NI 512.0m - CFO 866.0m) / TA 8.07b) |
| Beneish M-Score: -3.07 (Cap -4..+1) = AA |
What is the price of ZBRA shares?
Over the past week, the price has changed by +6.99%, over one month by -2.41%, over three months by -2.65% and over the past year by -33.28%.
Is ZBRA a buy, sell or hold?
- StrongBuy: 9
- Buy: 2
- Hold: 8
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the ZBRA price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 339.2 | 34.9% |
| Analysts Target Price | 339.2 | 34.9% |
| ValueRay Target Price | 238.4 | -5.2% |
ZBRA Fundamental Data Overview February 05, 2026
P/E Forward = 13.3869
P/S = 2.256
P/B = 3.2719
P/EG = 0.8525
Revenue TTM = 5.25b USD
EBIT TTM = 896.0m USD
EBITDA TTM = 1.06b USD
Long Term Debt = 2.11b USD (from longTermDebt, last quarter)
Short Term Debt = 102.0m USD (from shortTermDebt, last quarter)
Debt = 2.36b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.31b USD (from netDebt column, last quarter)
Enterprise Value = 13.16b USD (11.86b + Debt 2.36b - CCE 1.05b)
Interest Coverage Ratio = 4.62 (Ebit TTM 896.0m / Interest Expense TTM 194.0m)
EV/FCF = 16.62x (Enterprise Value 13.16b / FCF TTM 792.0m)
FCF Yield = 6.02% (FCF TTM 792.0m / Enterprise Value 13.16b)
FCF Margin = 15.07% (FCF TTM 792.0m / Revenue TTM 5.25b)
Net Margin = 9.74% (Net Income TTM 512.0m / Revenue TTM 5.25b)
Gross Margin = 48.39% ((Revenue TTM 5.25b - Cost of Revenue TTM 2.71b) / Revenue TTM)
Gross Margin QoQ = 48.03% (prev 47.64%)
Tobins Q-Ratio = 1.63 (Enterprise Value 13.16b / Total Assets 8.07b)
Interest Expense / Debt = 5.04% (Interest Expense 119.0m / Debt 2.36b)
Taxrate = 36.48% (58.0m / 159.0m)
NOPAT = 569.2m (EBIT 896.0m * (1 - 36.48%))
Current Ratio = 1.61 (Total Current Assets 2.58b / Total Current Liabilities 1.60b)
Debt / Equity = 0.63 (Debt 2.36b / totalStockholderEquity, last quarter 3.75b)
Debt / EBITDA = 1.23 (Net Debt 1.31b / EBITDA 1.06b)
Debt / FCF = 1.65 (Net Debt 1.31b / FCF TTM 792.0m)
Total Stockholder Equity = 3.64b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.50% (Net Income 512.0m / Total Assets 8.07b)
RoE = 14.05% (Net Income TTM 512.0m / Total Stockholder Equity 3.64b)
RoCE = 15.58% (EBIT 896.0m / Capital Employed (Equity 3.64b + L.T.Debt 2.11b))
RoIC = 9.79% (NOPAT 569.2m / Invested Capital 5.82b)
WACC = 10.68% (E(11.86b)/V(14.22b) * Re(12.17%) + D(2.36b)/V(14.22b) * Rd(5.04%) * (1-Tc(0.36)))
Discount Rate = 12.17% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.12%
[DCF Debug] Terminal Value 59.20% ; FCFF base≈782.4m ; Y1≈513.6m ; Y5≈234.3m
Fair Price DCF = 36.41 (EV 3.15b - Net Debt 1.31b = Equity 1.84b / Shares 50.7m; r=10.68% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: -37.42 | EPS CAGR: -48.11% | SUE: -4.0 | # QB: 0
Revenue Correlation: -34.78 | Revenue CAGR: -2.78% | SUE: 0.26 | # QB: 0
EPS next Quarter (2026-03-31): EPS=4.12 | Chg30d=+0.022 | Revisions Net=+0 | Analysts=14
EPS next Year (2026-12-31): EPS=17.67 | Chg30d=-0.037 | Revisions Net=+0 | Growth EPS=+11.5% | Growth Revenue=+9.9%